home - theme - highlights - programme - social events - call for papers - booking - press releases - awards

 

 

  Theme
  Safe, effective and appropriate medicines remain a cornerstone of healthcare provision. The benefits to patients of controlling disease and the pathologies of old age cannot be underestimated. Modern medicines are potent compounds that can bring life-saving treatments and relief of symptoms to millions of people. But the challenge of bringing safe and effective medicines to the market brings with it considerable risk for all stakeholders.
   
The theme of BPC 2007, The medicines maze: balancing risks and benefits, addresses the many facets of this conundrum. Reducing risk and maximising benefit must be addressed by scientists and the pharmaceutical industry, by the regulators and governments and by the patient and healthcare professionals.
  For scientists and the pharmaceutical industry, the risks involved in the introduction of new chemical entities are immense. Innovators endeavour to make medicines which are safe and effective. This involves engaging in costly clinical trials that might reveal unexpected pharmacological actions. These findings may affect reputations. Once a medicine has been brought to market, the pharmaceutical industry and regulators must work together to combat counterfeiting.  
The regulators need to show consistency in their approach to the risks and benefits of licensing and in issuing guidance on new medicines and other treatments, against the backdrop of increasing patient demands. Similarly, health service organisations face the challenge of balancing priorities and weighing up the risks and benefits of providing various services within finite resources.
For the healthcare professional, the challenges include the increasing awareness of patient need; the growth of litigation; and the myriad new treatments and guidance being launched each year. On top of this, they must balance the usual risks and benefits associated with diagnosis and treatments.
  Patients’ priorities and needs are, of course, at the heart of all decisions. Patients need a better way of understanding the risks and benefits of treatments in order that they can make informed decisions. Today, despite the growth in information in the media and on the Internet, patients and the public still need expert support for their health choices. The increasing popularity of complementary medicines or a reliance on traditional medicine are also risk factors. The RPSGB and other heath regulators must tackle the challenge of supporting a safe and workable framework for medicines development, management and delivery.  
  Balancing risks and benefits is therefore the challenge that patients, pharmacists and scientists have to face to find the most appropriate outcome. BPC 2007 will tackle all of these issues in the usual mix of leading edge scientific symposia, sessions on the challenges for policy and practice and lively discussions and debate.  
     
  The conference exhibition
  Continuing the theme of linking science and practice, a comprehensive exhibition will run alongside the conference from 10-12 September in the purpose-built exhibition halls of Manchester Central (formerly known as Manchester International Convention Centre). The exhibition will feature stands and demonstrations of interest to scientists and practitioners alike, to provide a wealth of information and new ideas. The conference exhibition will provide a one stop shop for all those wanting to learn about the latest developments in their field and to network with colleagues from home and abroad. Poster viewing, networking areas and catering will all be available in the exhibition area.

If you are interested in exhibiting your organisation's developments at BPC 2007 then email channey@health-links.co.uk for
further information. A wide range of sponsorship opportunities are also available.

   
 
  Repeating the success of BPC 2006, the exhibition area will also play host to a BPC-PJ Careers Forum. Here, organisations will be able to outline career opportunities within their organisation and arrange preliminary interviews with potential employees from across the profession.
   
  Manchester Central
 

Based in the centre of Manchester, Manchester Central (previously known as Manchester International Convention Centre) is one of the leading conference venues in Europe. Manchester is a lively city and is ideally placed with easy transport links for road, rail and air. The city has accommodation to suit all price ranges and some of the best shopping and restaurants in the country.

   
 
Accommodation
 
Accommodation is being arranged by Procon - Email kateL@procon-conferences.co.uk  Tel - 01423 564488
Click here for the online accommodation booking form.
 

Continuing Professional Development

 

BPC 2007 will be accredited by the College of Pharmacy Practice and attendance at the professional sessions may contribute towards College members meeting the College requirements for continuing education.

 

Attending BPC 2007 is an ideal opportunity to learn and to identify things that you have learned and may wish to enter into your Society CPD record. Further details of how you can do this will be available at the BPC.

 

 

 

Health Links

 
In 2007, the conference administration will be run on behalf of the RPSGB by:
Health Links,
Windsor House, 11A High Street,
Kings Heath,
Birmingham B14 7BB
Tel: 0121 248 3399
Fax: 0121 248 3390
email Angela Lyons for further information:
alyons@health-links.co.uk
   
 

top of this page ↑

   

home - theme - highlights - programme - social events - call for papers - booking - press releases - awards